Terms: = Liver cancer AND TBX3, TBX3-ISO, ENSG00000135111, 6926, O15119, XHL, UMS AND Prognosis
5 results:
1. Targeting TROY-mediated P85a/AKT/tbx3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma.
Liu B; Fang X; Kwong DL; Zhang Y; Verhoeft K; Gong L; Zhang B; Chen J; Yu Q; Luo J; Tang Y; Huang T; Ling F; Fu L; Yan Q; Guan XY
J Exp Clin Cancer Res; 2022 May; 41(1):182. PubMed ID: 35610614
[TBL] [Abstract] [Full Text] [Related]
2. Role of somatic mutations and chromosomal aberrations in the prognosis of uveal melanoma in a Spanish patient cohort.
Silva-Rodríguez P; Bande M; Fernández-Díaz D; Lago-Baameiro N; Pardo M; José Blanco-Teijeiro M; Domínguez F; Loidi L; Piñeiro A
Acta Ophthalmol; 2021 Nov; 99(7):e1077-e1089. PubMed ID: 33421325
[TBL] [Abstract] [Full Text] [Related]
3. Expression of tbx3 in Hepatocellular Carcinoma and Its Clinical Implication.
Li Z; Wang Y; Duan S; Shi Y; Li S; Zhang X; Ren J
Med Sci Monit; 2018 Dec; 24():9324-9333. PubMed ID: 30578408
[TBL] [Abstract] [Full Text] [Related]
4. Treatment of Uveal Melanoma.
Shoushtari AN; Carvajal RD
Cancer Treat Res; 2016; 167():281-93. PubMed ID: 26601868
[TBL] [Abstract] [Full Text] [Related]
5. Uveal melanoma hepatic metastases mutation spectrum analysis using targeted next-generation sequencing of 400 cancer genes.
Luscan A; Just PA; Briand A; Burin des Roziers C; Goussard P; Nitschké P; Vidaud M; Avril MF; Terris B; Pasmant E
Br J Ophthalmol; 2015 Apr; 99(4):437-9. PubMed ID: 25361747
[TBL] [Abstract] [Full Text] [Related]
